Company / Revenue
Nurix Therapeutics, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$84.0M
FY2025
5-year range
$29.8M / $84.0M
FY2021-FY2025
Trend
+54.0%
vs FY2024
Sector context
#110 of 155
Health Care
What the data says
At $84M, Nurix Therapeutics, Inc.'s revenue ranks #110 of 155 in the Health Care sector. Revenue has fluctuated over the past 7 years, ranging from $18M in FY2020 to $84M in FY2025.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +36.3%.
Improved from $77M to $84M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +41.3%
- 5-Year CAGR
- +36.3%
- 10-Year CAGR
- -
Sector benchmark
#110 of 155 in Health CareTop 71% of 155This company $84.0M Sector average $4.5B
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +36.3%, indicating consistent growth.
- In FY2025, revenue increased 54.0% year-over-year.
- Ranks #110 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $84.0M | +54.0% |
| FY2024 | $54.5M | -29.1% |
| FY2023 | $77.0M | +158.8% |
| FY2022 | $29.8M | -4.4% |
| FY2021 | $31.1M | +74.6% |
| FY2020 | $17.8M | -42.7% |
| FY2019 | $31.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026